Article

Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: Practical biomarkers and robust multiplex models

2024-01-03

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Platinum/taxane chemotherapy with debulking surgery stays the mainstay of the treatment in ovarian cancer patients with peritoneal metastasis. Recently its novel modality, intraperitoneal carboplatin with dose-dense paclitaxel (ddTCip), was shown to have greater therapeutic impact, but consequent recurrence or relapse still often occurs. Discovery of therapeutic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9f370bd1-0ad8-5f5c-8207-dc320f7e1932
DOI: 10.21203/rs.3.rs-3814637/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: Practical biomarkers and robust multiplex modelsDOI 10.21203/rs.3.rs-3814637/v1Read

Practical biomarkers and robust multiplex models for the prediction of response to promising first-line chemotherapy: A theranostic study in metastatic ovarian cancer patients with residual peritoneal tumorsSemantic proximity Read

Practical biomarkers and robust multiplex models for the prediction of response to the promising first-line chemotherapy: A theranostic study in metastatic ovarian cancer patients with residual peritoneal tumorsSemantic proximity Read

Construction and Validation of a Platinum Sensitivity Predictive Model With Multiple Genomic Variations for Epithelial Ovarian CancerSemantic proximity Read

Identification of platinum-resistance related small GTPase binding signatures to predict the prognosis of ovarian cancer by machine learning and integrated bioinformatic analysesSemantic proximity Read

Identification and Validation of a Novel Prognostic Model Based on Platinum Resistance-Related Genes in Bladder CancerSemantic proximity Read

Predicting Response to Platin Chemotherapy Agents with Biochemically-inspired Machine LearningSemantic proximity Read

Identification of Potential Markers for Differentiating Epithelial Ovarian Cancer from Ovarian Low Malignant Potential Tumors through Integrated Bioinformatics AnalysisSemantic proximity Read

Large-scale integrated analysis of ovarian cancer tumors and cell lines identifies an individualized gene expression signature for predicting response to platinum-based chemotherapySemantic proximity Read

Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patientsSemantic proximity Read

A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based ChemotherapySemantic proximity Read

Predicting responses to platin chemotherapy agents with biochemically-inspired machine learningSemantic proximity Read

Molecular Pathogenesis Early Detection Strategies and Precision Therapeutic Advances in Ovarian CancerSemantic proximity Read